VEGFA and androgen insensitivity syndrome: Consistent with this, Tang et al. treated patients with AIS with di-3-n-butylphthalide from the third to the 14th day after disease onset and observed increased serum levels of VEGF and basic fibroblast growth factor after treatment (Tang et al., 2017).